S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
DOW New Hghs Coming Sooner Than Later
On Holding AG Sprints Higher on Margin Expansion and Guidance
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
DOW New Hghs Coming Sooner Than Later
On Holding AG Sprints Higher on Margin Expansion and Guidance
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
DOW New Hghs Coming Sooner Than Later
On Holding AG Sprints Higher on Margin Expansion and Guidance
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
DOW New Hghs Coming Sooner Than Later
On Holding AG Sprints Higher on Margin Expansion and Guidance

Invitae - NVTA Price Target & Analyst Ratings

$1.32
+0.11 (+9.09%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.22
$1.35
50-Day Range
$1.21
$2.73
52-Week Range
$1.18
$9.18
Volume
11.06 million shs
Average Volume
9.39 million shs
Market Capitalization
$325.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.58

Invitae Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 11 Analyst Ratings

Consensus Analyst Price Target

$4.58
246.86% Upside
High Prediction$8.50
Average Prediction$4.58
Low Prediction$1.75
TypeCurrent
3/22/22 to 3/22/23
1 Month Ago
2/20/22 to 2/20/23
3 Months Ago
12/22/21 to 12/22/22
1 Year Ago
3/22/21 to 3/22/22
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
4 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
9 Hold rating(s)
3 Hold rating(s)
Sell
4 Sell rating(s)
4 Sell rating(s)
3 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$4.58$5.05$8.04$28.43
Predicted Upside246.86% Upside65.51% Upside49.36% Upside29.76% Upside
Get Invitae Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NVTA and its competitors with MarketBeat's FREE daily newsletter.

NVTA Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NVTA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Invitae Stock vs. The Competition

TypeInvitaeMedical CompaniesS&P 500
Consensus Rating Score
1.64
2.64
2.47
Consensus RatingHoldBuyHold
Predicted Upside246.86% Upside1,900.31% Upside20.87% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/3/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight$2.25 ➝ $1.75-3.85%
1/31/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Sell$2.00-19.35%
11/15/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$2.80-20.45%
11/9/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
P. Souda
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetMarket Perform$2.50 ➝ $3.00+22.95%
11/8/2022William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Brackmann
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
8/24/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageUnderperform
8/10/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underweight
7/21/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
7/20/2022LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
7/19/2022Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
2/15/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$37.00 ➝ $18.00+64.84%
11/9/2021Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$35.00 ➝ $25.00-4.83%
4/5/2021Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$48.00+22.48%
(Data available from 3/22/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












NVTA Price Target - Frequently Asked Questions

What is Invitae's consensus rating and price target?

According to the issued ratings of 11 analysts in the last year, the consensus rating for Invitae stock is Hold based on the current 4 sell ratings and 7 hold ratings for NVTA. The average twelve-month price prediction for Invitae is $4.58 with a high price target of $8.50 and a low price target of $1.75. Learn more on NVTA's analyst rating history.

Do Wall Street analysts like Invitae more than its competitors?

Analysts like Invitae less than other Medical companies. The consensus rating for Invitae is Hold while the average consensus rating for medical companies is Buy. Learn more on how NVTA compares to other companies.

Is Invitae being downgraded by Wall Street analysts?

Over the previous 90 days, Invitae's stock had 1 downgrade by analysts.

Does Invitae's stock price have much upside?

According to analysts, Invitae's stock has a predicted upside of 63.23% based on their 12-month price targets.

What analysts cover Invitae?

Invitae has been rated by Piper Sandler, and The Goldman Sachs Group in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:NVTA) was last updated on 3/22/2023 by MarketBeat.com Staff